Raymond Beaulieu

980 total citations
15 papers, 744 citations indexed

About

Raymond Beaulieu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Raymond Beaulieu has authored 15 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Raymond Beaulieu's work include Epigenetics and DNA Methylation (2 papers), Immune Cell Function and Interaction (2 papers) and Cancer Cells and Metastasis (2 papers). Raymond Beaulieu is often cited by papers focused on Epigenetics and DNA Methylation (2 papers), Immune Cell Function and Interaction (2 papers) and Cancer Cells and Metastasis (2 papers). Raymond Beaulieu collaborates with scholars based in Canada, France and United States. Raymond Beaulieu's co-authors include Danuta Balicki, Julie Douville, Louis Gaboury, Mohammadi Kaouass, Xiaoduan Weng, Guy Cloutier, Ghislaine O. Roederer, Emil Toma, Jean‐Pierre Routy and Guy Sauvageau and has published in prestigious journals such as Cancer, Journal of Controlled Release and The American Journal of Medicine.

In The Last Decade

Raymond Beaulieu

15 papers receiving 723 citations

Peers

Raymond Beaulieu
Nanda K. Thudi United States
Rob de Waal Netherlands
Jason R. Neil United States
Ronglin Xie United States
Benjamin Tiede United States
Mumtaz V. Rojiani United States
Hyung‐Gyoon Kim United States
Patrick B. Lappin United States
Raymond Beaulieu
Citations per year, relative to Raymond Beaulieu Raymond Beaulieu (= 1×) peers Laurence Maggiorella

Countries citing papers authored by Raymond Beaulieu

Since Specialization
Citations

This map shows the geographic impact of Raymond Beaulieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Beaulieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Beaulieu more than expected).

Fields of papers citing papers by Raymond Beaulieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond Beaulieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Beaulieu. The network helps show where Raymond Beaulieu may publish in the future.

Co-authorship network of co-authors of Raymond Beaulieu

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond Beaulieu. A scholar is included among the top collaborators of Raymond Beaulieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond Beaulieu. Raymond Beaulieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Douville, Julie, Raymond Beaulieu, & Danuta Balicki. (2008). ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells. Stem Cells and Development. 18(1). 17–26. 265 indexed citations
2.
Beaulieu, Raymond, et al.. (2008). Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics. Molecular Cancer Therapeutics. 7(4). 740–748. 42 indexed citations
3.
Kaouass, Mohammadi, Raymond Beaulieu, & Danuta Balicki. (2006). Histonefection: Novel and potent non-viral gene delivery. Journal of Controlled Release. 113(3). 245–254. 67 indexed citations
4.
Gaboury, Louis, et al.. (2006). SP analysis may be used to identify cancer stem cell populations. Experimental Cell Research. 312(19). 3701–3710. 236 indexed citations
5.
Weng, Xiaoduan, Ghislaine O. Roederer, Raymond Beaulieu, & Guy Cloutier. (1998). Contribution of Acute-Phase Proteins and Cardiovascular Risk Factors to Erythrocyte Aggregation in Normolipidemic and Hyperlipidemic Individuals. Thrombosis and Haemostasis. 80(12). 903–908. 49 indexed citations
6.
Cloutier, Guy, et al.. (1997). Differences in the erythrocyte aggregation level between veins and arteries of normolipidemic and hyperlipidemic individuals. Ultrasound in Medicine & Biology. 23(9). 1383–1393. 20 indexed citations
7.
Vanhems, Philippe, et al.. (1996). Prognostic value of the CD4+ T cell count for HIV-1 infected patients with advanced immunosuppression. International Journal of STD & AIDS. 7(7). 495–501. 3 indexed citations
8.
Routy, Jean‐Pierre, et al.. (1993). Increase of hemoglobin A2 in human immunodeficiency virus‐1‐infected patients treated with zidovudine. American Journal of Hematology. 43(2). 86–90. 17 indexed citations
9.
Quérin, Serge, Walter Schürch, & Raymond Beaulieu. (1992). Ciclosporin in Goodpasture’s Syndrome. ˜The œNephron journals/Nephron journals. 60(3). 355–359. 4 indexed citations
10.
Routy, Jean‐Pierre, et al.. (1991). Immunologic thrombocytopenia followed by thrombotic thrombocytopenic purpura in two HIV1 patients. American Journal of Hematology. 38(4). 327–328. 22 indexed citations
11.
Beaulieu, Raymond, et al.. (1991). Acute and Delayed Emesis after Cisplatin-Based Regimen: Description and Prevention. Oncology. 48(5). 392–396. 9 indexed citations
12.
Beaulieu, Raymond. (1988). Who's Who. Journal of Palliative Care. 4(4). 8–8. 1 indexed citations
14.
Beaulieu, Raymond, et al.. (1976). Immunologic studies of human plasma cells. American Journal of Hematology. 1(3). 325–330. 1 indexed citations
15.
Pirofsky, Bernard, et al.. (1974). Antithymocyte antiserum effects in man. The American Journal of Medicine. 56(3). 290–296. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026